Creative Biolabs Introduces Anti-Glycopeptide Antibody Discovery Workflow to Accelerate Cancer Therapeutic Development
Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak immunogenicity and antigen instability. SHIRLEY, NY, UNITED STATES, June 29, 2026 /EINPresswire.com/ -- Creative Biolabs announced …